Nanophase Announces Strategic Collaboration ROMEOVILLE,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
89
Nanophase Announces Strategic Collaboration

ROMEOVILLE, Ill., June 29, 2017 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB:NANX), a technology leader in nanomaterials and advanced nanoengineered products, today reported the execution of development, manufacturing and distribution agreements with Eminess Technologies, Inc., a premier manufacturer and distributor of products for polishing of critical surfaces, to enhance their mutual positions in supplying advanced material solutions to the surface finishing marketplace. 

“Our companies have known each other for quite some time.  We expect this relationship to extend the reach of our products to a broader market, allow for a higher degree of focus on customer support in polishing and surface finishing areas where Eminess is more deeply established than Nanophase, and also to foster the development of new markets and products that are squarely within the Eminess strategic focus.  We believe that our material solutions will offer Eminess a market advantage, while allowing Nanophase to quickly deepen a successful supply position in those markets,” stated Nanophase CEO, Jess Jankowski.  Dan Koharko, CEO of Eminess added, “These agreements enhance our ability to deliver the technology to our customers who require advanced materials and application knowledge to produce their critical, next generation products.  Our quick, efficient development, manufacturing, and supply chain ensures that current and future world-class Nanophase particle technology is accessible to all that would benefit from it.”    

“Eminess will begin to manufacture selected Nanophase product lines, and exclusively distribute others.  Included in these arrangements, the companies will implement a royalty agreement for certain future sales, along with certain minimum revenue volumes to ensure ongoing benefit for both organizations while we work together to best serve customers in this market,” said Jankowski.

“In terms of our transition, the shared goal of Nanophase and Eminess is to have all the commercial and organizational coordination completed in time for the Optifab 2017 exhibition to be held in Rochester, New York, beginning October 16 th of this year.”

Jankowski continued, “This collaboration reflects another step in executing the Nanophase strategy of focusing our business development resources on the continued rollout of our new fully formulated personal care, and solar-control solutions, while allowing us to remain engaged and continuing to profit from our well-proven capabilities in the surface finishing marketplace.” 

About Nanophase Technologies Nanophase Technologies Corporation (NANX), www.nanophase.com , is a leader in nanomaterials technologies and provides nanoengineered solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2008 and ISO 14001 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media. 

Forward-Looking Statements This press release contains words such as “expects,” ”shall,” “will,” “believes,” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: the Company’s ability to be consistently profitable despite the losses it has incurred since its incorporation; a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; the terms of the Company’s supply agreements with BASF Corporation, which could trigger a requirement to transfer technology and/or sell equipment to that customer; the Company’s potential inability to obtain working capital when needed on acceptable terms or at all; the Company’s ability to obtain materials at costs it can pass through to its customers, including Rare Earth elements, specifically cerium oxide, as well as high purity zinc; uncertain demand for, and acceptance of, the Company’s nanocrystalline materials; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation or other legal proceedings in which the Company may become involved; the impact of any potential new government regulations that could be difficult to respond to or too costly to comply with while remaining financially viable; the ability of the Company to maintain an appropriate electronic trading venue for its securities; and other factors described in the Company’s Form 10-K filed March 29, 2017. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.

COMPANY CONTACT Frank Cesario Investor Relations 630-771-6705

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Photocure Navigates AssureMDx's Medicare Journey

Updated Category News Views 21

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Continue Reading
Segway Powersports Ventures into Baja 1000: Ambitions Run High

Updated Category News Views 124

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 172

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

Updated Category News Views 14

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 510

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
UAE Pioneers eATA Carnet System Beyond Europe

Updated Category News Views 7

Breaking Tradition with Digital Innovation Well, who would’ve thought? The UAE just leapt ahead in the trade game, becoming the first to roll out the eATA Carnet system beyond the cozy confines of Europe. This isn’t some run-of-the-mill tech rollout, folks. It’s a digital revolution in how temporary imports are handled—goodbye paper, hello efficiency! With this...

Continue Reading
Valmet Expands Board Maker Deal in Asia With New Line

Updated Category News Views 87

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 370

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
AI Agents Redefine Finance: Deutsche & Ant Tech

Updated Category News Views 16

AI Agents: Shaping the Future of Finance The finance world has always been about numbers and precision, but now, with the advent of AI, it’s entering a domain where machines could call the shots. Hold your horses before you imagine free-wheeling robots in suits; this is still the finance sector, where control and audits are holy grails. Deutsche Bank and Ant's Ambitious...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 490

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

First Savings Financial Group Shares Exciting Dividend News

Updated Category News Views 159

First Savings Financial Group, Inc. Declares Special Cash Dividend In a recent announcement, First Savings Financial Group, Inc. (NASDAQ: FSFG), a prominent holding company, revealed that their Board of Directors has approved a quarterly cash dividend of $0.16 per common share. This generous dividend is a reflection of the company’s positive financial health and...

Continue Reading
Ransomware Attacks Surge: Insights from Coalition's Findings

Updated Category News Views 222

Ransomware Attacks Surge: Insights from Coalition's Findings SAN FRANCISCO-- Coalition, the world's first Active Insurance provider designed to prevent digital risk before it strikes, has published its latest findings revealing a significant turnaround in the landscape of cyber threats. Recent statistics show that ransomware claims severity has increased by 68%, reaching...

Continue Reading
Metropolitan Commercial Bank's ACH Cloud Shift: Game Changer or Risky Play?

Updated Category News Views 250

On February 17, 2026, Metropolitan Commercial Bank (MCB) completed a major transition by fully retiring its legacy ACH mainframe and moving to Finzly’s cloud-native payment platform. This move positions MCB as a pioneer among U. S. banks as the industry grapples with modernizing aging systems—a reality that has been highlighted by looming regulatory changes. You know...

Continue Reading
GEODIS Names Laura Ritchey President & CEO of Americas Region

Updated Category News Views 401

GEODIS Appoints New President and CEO for the Americas GEODIS, a prominent figure in the logistics and transportation industry, has announced the appointment of Laura Ritchey to the position of President & CEO of its Americas region. In this crucial role, Ritchey will be part of the Group's Executive Board and will report to Marie-Christine Lombard, the Group's Chief...

Continue Reading
Conagra Brands Set to Share Fiscal 2026 Q2 Earnings Announcement

Updated Category News Views 341

Conagra Brands Announces Earnings Release Date Conagra Brands, Inc. (NYSE: CAG) recently made a significant announcement regarding its fiscal 2026 second quarter results. The much-anticipated earnings release is scheduled for a Friday, marking an important milestone for the company and its stakeholders. Details of the Earnings Call The earnings call will take place on a...

Continue Reading